of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19
) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 9M/2022 (01/04/21 -31/12/21) 9M/2021 (01/04/20
Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18 -31/12/18) Accounting Type Consolidate Consolidate Consolidate Consolidate
revenue proportion YEAR 2018 & YEAR 2019 & 1Q20 From the chart, it can be seen that the proportion of income from the 4 main structures of the company, there is a change in revenue from retail stores that
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
to an incre s, the detai e Income an e income a than the 3rd income an 16 of 33.7% ing the 3rd q d and bever Service Inc urred rental e 3rd quarter is, Q3/2017 Discussion a hange of Th c Company
period to an incre s, the detai e Income an e income a than the 3rd income an 16 of 33.7% ing the 3rd q d and bever Service Inc urred rental e 3rd quarter is, Q3/2017 Discussion a hange of Th c Company
) Administrative expenses 405.63 435.73 (30.10) (6.9) Finance costs 434.76 400.37 34.39 8.6 Income tax expense 229.05 247.06 (18.01) (7.3) Total expenses 2,264.28 2,421.06 (156.78) (6.5) 1,133.06 1,095.13 37.93 3.5
Company Limited (“the Company”) and its Subsidiary (“the Group”) would like to clarify the change in operating result for the 2nd Quarter ended 30 June 2020, which changed in revenue and net profit compared
trademark “Wuttisak Clinic”, which start operate the franchise business on February 10, 2018. So far we can generate income for each branch continuously. 3. Analysis of Operating Results Statements of